Decreased blood pressure variability at rest in patients with primary aldosteronism

American Journal of Hypertension

Volumn 11, Issue 7, 1998, Pages 828-838

  Munakata, Masanori ^a,b   Aihara, Akiko ^a   Imai, Yutaka ^a   Abe, Keishi ^a   Yoshinaga, Kaoru ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU ROSAI HOSPITAL   (Japan)

Author keywords

Baroreflex; Blood pressure variability; Hypertension; Primary aldosteronism

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MALE; PRESSORECEPTOR REFLEX; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REST; RR INTERVAL; STANDING; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE;

ADULT; ALDOSTERONE; BAROREFLEX; BLOOD PRESSURE; DIASTOLE; EXERCISE; FEMALE; HEART RATE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; NOREPINEPHRINE; POSTURE; RENIN; SUPINE POSITION; SYSTOLE;

EID: 0032127208     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00058-2     Document Type: Article

References (40)

1. 1. Parati G, Pomidossi G, Albini F, et al: Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987;5:93-98.
2. 2. Bristow JD, Honour AJ, Pickering GW, et al: Diminished baroreflex sensitivity in high blood pressure. Circulation 1969;39:48-54.
3. 3. Gribbin B, Pickering TG, Slight P, Peto R: Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971;29:424-431.
4. 4. Frattola A, Parati G, Cuspidi C, et al: Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11:1133-1137.
5. 5. Munakata M, Aihara A, Imai Y, et al: Increased gain in baroreceptor-heart rate reflex in patients with primary aldosteronism. J Hypertens 1995;13:1648-1653.
6. 6. Mancia G, Ferrari A, Gregorini L, et al: Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983;53:96-104.
7. 7. Kaplan NM: Primary aldosteronism, in Kaplan NM (eds): Clinical Hypertension, ed 6. Williams & Wilkins, Baltimore, 1994, pp 389-408.
8. 8. Abe K, Irokawa N, Yasujima M, et al: The kallikreinkinin system and prostaglandins in the kidney. Circ Res 1978;43:254-260.
9. 9. Miura Y, Campese V, DeQuattro V, Meijer D: Plasma catecholamines via an improved fluorometric assay: comparison with an enzymatic method. J Lab Clin Med 1977;89:421-427.
10. 10. Munakata M, Imai Y, Mizunashi K, et al: The effect of graded calcium infusion on rhythmic blood pressure oscillations in normal man. Clin Auto Res 1995;5:5-11.
11. 11. Munakata M, Imai Y, Takagi H, et al: Altered frequency-dependent characteristics of the cardiac baroreflex in essential hypertension. J Auto Nerv Syst 1994;49:33-45.
12. 12. Daffonchio A, Franzelli C, Radaelli A, et al: Sympathectomy and cardiovascular spectral components in conscious normotensive rats. Hypertension 1995;25:1287-1293.
13. 13. Mulder LJM, van Dellen HJ, van der Meulen P, Opheikens B: CARSPAN: a spectral analysis program for cardiovascular time series, in Maarse FJ, Mulder LJM, Sjouw W, and Akkerman A (eds): Computers in Psychology: Methods, Instrumentation and Psychodiagnostics. Swets & Zeitlinger, Lisse, Netherlands, 1988, pp 39-47.
14. 14. Mulder LJM: Spectral analysis of cardiovascular time series with the discrete fourier transform, in Mulder LJM (ed) Assessment of Cardiovascular Reactivity by Means of Spectral Analysis. University of Groningen, Groningen, Netherlands, 1988, pp 51-72.
15. 15. Pagani M, Somers V, Furlan R, et al: Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 1988;12:600-610.
16. 16. Robbe HWJ, Mulder LJM, et al: Assessment of baroreflex sensitivity by means of spectral analysis. Hypertension 1987;10:538-543.
17. 17. Omboni S, Parati G, Villani A, et al: Reproducibility of time and frequency domain indexes of spontaneous baroreflex sensitivity in hypertensive subjects (abst). J Hypertens 1997;15(suppl 4):s20.
18. 18. Villani A, Omboni S, Parati G, et al: Reproducibility of time and frequency domain indexes of finger blood pressure variability in hypertensive subjects (abst). J Hypertens 1997;15(suppl 4):s204.
19. 19. Cerutti C, Gustin MP, Paultre CZ, et al: Autonomic nervous system and cardiovascular variability in rats: a spectral approach. Am J Physiol 1991;261:H1292-H1299.
20. 20. Akselrod S, Gordon D, Madwed JB, et al: Hemodynamic regulation: investigation by spectral analysis. Am J Physiol 1985;249:H867-H875.
21. 21. Miyajima E, Yamada Y, Yoshida Y, et al: Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991;17: 1057-1062.
22. 22. Furlan R, Dell'Orto S, Crivellaro W, et al: Effects of tilt and treadmill exercise on short-term variability in systolic arterial pressure in hypertensive men. J Hypertens 1987;5(suppl 5):s423-s425.
23. 23. Piazza S, Furlan R, Dell'Orto S, et al: Mechanical effects of respiration and stepping on systolic arterial pressure variability during treadmill exercise. J Hypertens 1995; 13:1643-1647.
24. 24. Mancia G, Grassi G, Parati G, Daffonchio A: Evaluating sympathetic activity in human hypertension. J Hypertens 1993;11(suppl 5):s13-s19.
25. 25. Galbo H: The hormonal response to exercise. Diab Metab Rev 1988;1:385-408.
26. 26. Peronnet F, Beliveau L, Boudreau G, et al: Regional plasma catecholamine removal and release at rest and exercise in dogs. Am J Physiol 1988;254:R663-R672.
27. 27. Ray CA, Rea RF, Clary MP, Mark AL: Muscle sympathetic nerve response to dynamic one-legged exercise: effect of body posture. Am J Physiol 1993;264:H1-H7.
28. 28. Mark AL: Regulation of sympathetic nerve activity in mild human hypertension. J Hypertens 1990;8:s67-s75.
29. 29. Macor F, Fagard R, Amery A: Power spectral analysis of RR interval and blood pressure short-term variability at rest and during dynamic exercise: comparison between cyclists and controls. Int J Sports Med 1996;17: 175-181.
30. 30. van de Borne P, Nguyen H, Biston P, et al: Effects of wake and sleep stages to the 24-hour autonomic control of blood pressure and heart rate in recumbent men. Am J Physiol (Heart Circ Physiol 35) 1994;266:H548-H554.
31. 31. Siche JP, Herpin D, Asmar RG, et al: Non-invasive ambulatory blood pressure variability and cardiac baroreflex sensitivity. J Hypertens 1995;13:1654-1659.
32. 32. Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24: 793-801.
33. 33. Ramirez AJ, Castiglioni P, Waissmann P, et al: Relationship of non-invasive finger blood pressure means and variability to left ventricular mass in essential hypertension (abst). J Hypertens 1997;15(suppl 4):s19.
34. 34. Rossi GP, Sacchetto A, Visentin P, et al: Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996;27: 1039-1045.
35. 35. Shigematsu Y, Hamada M, Okayama H, et al: Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997; 29:723-727.
36. 36. Tanabe A, Naruse M, Naruse K, et al: Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997;20:85-90.
37. 37. Takeda R, Matsubara T, Mlyamori I, et al: Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. J Endocrinol Invest 1995;18: 370-373.
38. 38. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
39. 39. Brilla CG, Matsubara LS, Weber KT: Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 1993;71: 12A-16A.
40. 40. Young M, Fullerton M, Dilley R, Funder J: Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 1994;93:2578-2583.